Report License
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Order Review
Recombinant Protein Therapeutics CDMO Market – Type (Oncology Agents, Insulin, Interferon, Vaccine), Source (Mammalian, E. coli), Therapeutic Area (Oncology, Immunological, Metabolic Disorders), Service Type, End-user, Global Forecast (2024 – 2032)
Report ID: GMI8819
Selected License: $8,350
Discount: $2,505
Order Total: $5,845
Need assistance?
Call us or write to us:
Phone : +1-302-846-7766
Toll-Free : +1-888-689-0688
Email: sales@gminsights.com
